A top Republican leader has slammed the ruling Democratic party and the Center for Disease Prevention and Control for reimposing a mask mandate for vaccinated people in certain circumstances, alleging that the latest regulation is based on data from India.
Congressman Kevin McCarthy, House Minority Leader, was speaking against a bill that proposed to reinstitute a mask mandate in the House of Representatives.
He alleged that the latest recommendations by the Center for Disease Prevention and Control (CDC) is based on a report that has not been reported yet.
The Republican leader, however, did not specify the report.
Referring to a conversation he had with a House doctor, McCarthy said that the report was based upon India about a vaccine that is not approved in America.
House Speaker Nancy Pelosi slammed the opposition leader and described him as a moron.
However, McCarthy asserted that the Indian report did not even pass peer review.
The mask mandate is based upon a study in India, based upon a vaccine that isn't approved in America that didn't pass peer review. Could this be a plan to keep our schools closed? he asked.
His fellow Republican, Congressman Dan Crenshaw joined him on social media to support him.
Here's the truth, America: The game changer data the CDC used for the mask mandate is from a single study from India. The study was rejected in peer review. But the CDC used it anyway. Remember what I said about public health officials losing our trust? It gets worse, he said on Twitter.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)